Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04193683
Other study ID # bvubcinar01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 15, 2019
Est. completion date February 28, 2020

Study information

Verified date December 2021
Source Bezmialem Vakif University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study was to investigate the effect of myofascial release technique on rib cage mobility, respiratory function, respiratory muscle strength and endurance in patients with hamstring muscle shortness.


Description:

Hamstring flexibility is important to maintain activities such as walking and running in daily life. Hamstring muscle shortness, commonly seen in the community, is a risk factor for many musculoskeletal pathologies. Clinical observations have shown that the shortness of the Hamstring muscle causes spinal malalignment. This deterioration of the spine alignment may adversely affect the rib cage expansion. Moreover, considering that the optimal length of the muscles provides optimal contraction, it was found that the spinal malalignment adversely affected the effective contraction of the diaphragm by changing the position of diaphragm. A different view is that, because the fascia functions as a single tissue surrounding the entire body, a restriction in the hamstring muscle can also cause a restriction in distal muscles such as diaphragm through the fascia. There are many treatment methods used to increase the flexibility of the hamstring muscle. One of these methods is the myofascial release technique. In this technique, which targets both muscle and fascia, applying light and prolonged pressure provides the myo-fascial complex to reach its optimal length, resulting in the optimal function of the muscle. In our best knowledge, no study has evaluated the effect of myofascial release technique on respiratory parameters in patients with hamstring muscle shortness.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date February 28, 2020
Est. primary completion date February 18, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - more than 15 degrees knee flexion angle during popliteal angle test, - no generalized joint laxity according to Beighton Criteria, and - no musculoskeletal problems of lower extremities. Exclusion Criteria: - history of lower extremity and/or axial skeletal fracture; - recent muscle, tendon injury in lower extremity; - history of lumbal disc herniation, arthritic and/or inflammatory disease; - obesity, diabetes and/or metabolic syndrome; - history of surgery in the last month, - using muscle relaxant medication in the last month; - received manual therapy in the last month

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Myofascial Release Technique
Myofascial release technique will bi applied bottom of the feet, back of the legs and hamstrings in both extremities. The practitioner will decide how long she should stay in a region according to the feeling of releasing in the tissue. The technique will be applied to a region at least 3 times.
Sham-Ultrasound
Sham-ultrasound will be applied to back of legs and thighs in both extremities without pressure and all parameters of the ultrasound device except the timer will be closed.

Locations

Country Name City State
Turkey Bezmialem Vakif University Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Bezmialem Vakif University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline Forced Vital Capacity (FVC) at 60 minutes Respiratory Function Test 60 minutes
Primary Change from baseline Forced Expiratory Volume in 1 second (FEV1) at 60 minutes Respiratory Function Test 60 minutes
Primary Change from baseline FEV1/FVC at 60 minutes Respiratory Function Test 60 minutes
Primary Change from baseline Peak Expiratory Flow (PEF) at 60 minutes Respiratory Function Test 60 minutes
Primary Change from baseline Forced expiratory flow over the middle one half of the FVC (FEF25-75%) at 60 minutes Respiratory Function Test 60 minutes
Primary Change from baseline maximum inspiratory pressure (MIP) at 60 minutes Respiratory Muscle Strength Test 60 minutes
Primary Change from baseline maximum expiratory pressure (MEP) at 60 minutes Respiratory Muscle Strength Test 60 minutes
Primary Change from baseline constant inspiratory threshold load test at 60 minutes Respiratory Muscle Endurance Test 60 minutes
Secondary Change from baseline axillary region chest circumference measurement during inspiration at 60 minutes Chest Circumference Measurement 60 minutes
Secondary Change from baseline axillary region chest circumference measurement during expiration at 60 minutes Chest Circumference Measurement 60 minutes
Secondary Change from baseline xiphoid region chest circumference measurement during inspiration at 60 minutes Chest Circumference Measurement 60 minutes
Secondary Change from baseline xiphoid region chest circumference measurement during expiration at 60 minutes Chest Circumference Measurement 60 minutes
Secondary Change from baseline subcostal region chest circumference measurement during inspiration at 60 minutes Chest Circumference Measurement 60 minutes
Secondary Change from baseline subcostal region chest circumference measurement during expiration at 60 minutes Chest Circumference Measurement 60 minutes
Secondary Change from baseline axillary region chest expansion test at 60 minutes Chest Circumference Measurement 60 minutes
Secondary Change from baseline xiphoid region chest expansion test at 60 minutes Chest Circumference Measurement 60 minutes
Secondary Change from baseline subcostal region chest expansion test at 60 minutes Chest Circumference Measurement 60 minutes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05008731 - Effect of Botulinum Toxin on Hamstring Contracture and the Occurrence of Cyclops Syndrome After Anterior Cruciate Ligament Reconstruction Phase 3
Completed NCT04334772 - Percutaneous Microelectrolysis in Agility, Joint Range and Strength N/A
Recruiting NCT05931120 - Comparison of Dry Needling and IASTM on Hamstring Tightness in Posterior Pelvic Tilt N/A
Completed NCT05866913 - Neurodynamics vs. Stretching in Soccer Players With Short Hamstring Syndrome N/A
Completed NCT03589573 - Effect of Muscle Strength on Hamstring Flexibility in Children With Duchenne Muscular Dystrophy
Completed NCT03178604 - Classic and Sham Massage on Psychological and Physical Functional Variables in Athletes N/A
Completed NCT03637439 - Neuromodulation in Patients With Hamstring Shortening N/A
Completed NCT04716205 - Mulligan's Bent Leg Raise Technique in Healthy Females N/A
Recruiting NCT04778293 - Effects of Diacutaneous Fibrolysis on Passive Neuromuscular Response N/A
Completed NCT04668092 - Functional DN for Shortened HS Muscle N/A
Completed NCT04784741 - Effect of Low Amplitude Vibration Therapy on Flexibility of Hamstring Muscle in Athletes of Pakistan N/A
Recruiting NCT05793242 - Immediate and 24-hour Effects of HyperVolt, Body Tempering, and Cupping Compared to Stretching on Hamstring Flexibility N/A
Recruiting NCT04827082 - Effects of Diacutaneous Fibrolysis on Flexibility and Active Neuromuscular Response N/A